FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pier Luigi Zinzani

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Enrico Derenzini; Cinzia Pellegrini; Stefano Pileri; Lisa Argnani; Beatrice Casadei; Pier Luigi Zinzani
Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series.
Pier Luigi Zinzani; Giovanni Barosi; Atto Billio; Angelo Michele Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Luigi Rigacci; Corrado Tarella; Sante Tura; Umberto Vitolo
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
Maria Grazia Bernengo; Marco Santucci; Pier Luigi Zinzani
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pier Luigi Zinzani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Enrico Derenzini; Cinzia Pellegrini; Stefano Pileri; Lisa Argnani; Beatrice Casadei; Pier Luigi Zinzani
Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series.
Clinical lymphoma, myeloma & leukemia 2013;13(3):258-65.
2013: Pier Luigi Zinzani; Giovanni Barosi; Atto Billio; Angelo Michele Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Luigi Rigacci; Corrado Tarella; Sante Tura; Umberto Vitolo
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
American journal of hematology 2013;88(3):185-92.
2012: Maria Grazia Bernengo; Marco Santucci; Pier Luigi Zinzani
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia 2012;147(6):513.
2012: Pietro Quaglino; Serena Rupoli; Stefano Titli; Pier Luigi Zinzani; Mauro Alaibac; Giuseppe Alfonso Lombardo; Maria Grazia Bernengo; Emilio Berti; Ugo Bottoni; Piergiacomo Calzavara-Pinton; Angelo Carbone; Paolo Fava; Michele Fimiani; Angela Maria Mamusa; Nicola Pimpinelli
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Cancer 2012;118(23):5830-9.
2012: Pier Luigi Zinzani; Lisa Argnani; Mario Arpinati; Francesca Bonifazi; Beatrice Casadei; Elisa Dan; Maria Rosa Motta; Cinzia Pellegrini; Marta Stanzani; Giuseppe Bandini
Hairy cell leukemia: allogeneic transplantation could be an optimal option in selected patients.
Clinical lymphoma, myeloma & leukemia 2012;12(4):287-9.
2012: Ruth Pettengell; David Rizzieri; Gary Schiller; Lixia Wang; Pier Luigi Zinzani; Giles Boland; Paul Cernohous; Bertrand Coiffier; Fernando Hurtado de Mendoza; Raghunadharao Digumarti; Henry Gomez; Igor Gorbatchevsky; Christine Kuepfer; Geetha Narayanan; jack w singer
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.
The lancet oncology 2012;13(7):696-706.
2012: Luigi Rigacci; Delia Rota-Scalabrini; Sergio Storti; Francesco Zaja; Pier Luigi Zinzani; Anna Marina Liberati; Enrico Orciuolo; Caterina Patti; Andrea Piccin; Benedetta Puccini; Monica Balzarotti; Velia Bongarzoni; Alberto Bosi; Andrea Carpaneto; Sergio Cortelazzo; Alfonso D'Arco; R Freilone; Gianluca Gaidano; Marco Gobbi; Emilio Iannitto
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
Annals of hematology 2012;91(7):1013-22.
2012: Christoph Renner; Andreas Trojan; Pier Luigi Zinzani; Mario Bargetzi; Francesco Bertoni; Christine Biaggi; Krimo Bouabdallah; Peter Brauchli; Sergio B Cogliatti; Pierre-Yves Dietrich; Michele Ghielmini; Rémy Gressin; Emmanuel Gyan; Felicitas Hitz; Nicolas Ketterer; Dirk Klingbiel; Andreas Lohri; Giovanni Martinelli; Walter Mingrone
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Haematologica 2012;97(7):1085-91.
2012: Alessandro Broccoli; Luca Faccioli; Marco Pastore Trossello; Luca Spinardi; Vittorio Stefoni; Claudio Agostinelli; Pier Luigi Zinzani
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature.
Rheumatology international 2012;32(7):2209-13.
2012: Anas Younes; Pier Luigi Zinzani; Dina Ben-Yehuda; Jennifer Gallagher; Simon J Harrison; Patrick Johnston; Mark Kirschbaum; Christophe Le Corre; Tee-Chuan Ong; H Miles Prince; Angela Shen; Anna Sureda; Andreas Engert
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2197-203.
2012: Egesta Lopci; Ivan Santi; Lucia Zanoni; Pier Luigi Zinzani; Arturo Chiti; Cristina Fonti; Stefano Fanti
FDG PET/CT predictive role in follicular lymphoma.
European journal of nuclear medicine and molecular imaging 2012;39(5):864-71.
2012: Pier Luigi Zinzani; Paolo Corradini; Andrea Gallamini; Alberto Grossi; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Giuseppe Rossi; Umberto Vitolo
Overview of alemtuzumab therapy for the treatment of T-cell lymphomas.
Leukemia & lymphoma 2012;53(5):789-95.
2012: Pier Luigi Zinzani; L Argnani; A Broccoli; E Cavalieri; Amalia De Renzo; Enrico Derenzini; Stefano Fanti; Mariapaola Fina; L Gandolfi; Gian Carlo Montini; Cinzia Pellegrini; Stefano Pileri; Alessandro Pulsoni; F Quirini; M Rossi; F Scopinaro; Vittorio Stefoni; Monica Tani; F Torelli; Michele Baccarani
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):415-20.
2012: Pier Luigi Zinzani
The many faces of marginal zone lymphoma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012;2012():426-32.
2012: Sylvia Hartmann; Stefano Pileri; Pier Luigi Zinzani; Claudio Agostinelli; Lothar Bergmann; Jürgen Diener; Claudia Döring; Stefano Fanti; Andrea Gallamini; Martin-Leo Hansmann
GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers.
BMC cancer 2012;12():586.
2012: Pier Luigi Zinzani; Rena Buckstein; Dolores Caballero; Yusri A Elsayed; Christopher Enny; Dixie-Lee Esseltine; Bernardo Garicochea; Nuriet K Khuageva; Pierre Soubeyran; Panteli Theocharous; Achiel Van Hoof; Jan Walewski; Huaqing Wang; Eugene Zhu; Bertrand Coiffier
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial.
Journal of hematology & oncology 2012;5():67.
2012: Monica Bellei; Maria Elena Cabrera; Carlos Sergio Chiattone; Joseph Michael Connors; Carmino Antonio De Souza; Francine Mary Foss; Raul Gabús; Steven Michael Horwitz; Raymond Liang; stefano luminari; Jorge Milone; Silvia Montoto; Astrid Pavlovsky; Emanuela Anna Pesce; Stefano Aldo Pileri; Aaron Polliack; Julie Marie Vose; Pier Luigi Zinzani; Lucia Zoppegno; Lucia Zoppegno; Emanuele Zucca; Massimo Federico
T-cell lymphomas in South america and europe.
Revista brasileira de hematologia e hemoterapia 2012;34(1):42-7.
2012: Pier Luigi Zinzani; Lisa Argnani; Michele Baccarani; Alessandro Broccoli; Antonio Castagnoli; Benedetta Puccini; Luigi Rigacci; Vittorio Stefoni; Luca Vaggelli; Lucia Zanoni; Stefano Fanti
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients.
European journal of nuclear medicine and molecular imaging 2012;39(1):4-12.
2011: Pier Luigi Zinzani
PET in T-Cell Lymphoma.
Current hematologic malignancy reports 2011;6(4):241-4.
2011: Pier Luigi Zinzani; Lisa Argnani; Alessandro Broccoli; Enrico Derenzini; Letizia Gandolfi; Cinzia Pellegrini; Stefano Pileri; Federica Quirini; Vittorio Stefoni; Michele Baccarani
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
Clinical lymphoma, myeloma & leukemia 2011;11(6):462-6.
2011: Michael Pfreundschuh; Viola Poeschel; Lois Shepherd; Ofer Shpilberg; Rolf Stahel; Marek Trneny; Lorenz Trümper; Jan Walewski; Pier Luigi Zinzani; Peter de Nully Brown; Devinder S Gill; Sandra Grass; Ulrich Jaeger; Evelyn Kuhnt; Stein Kvaloy; Markus Loeffler; Armando López-Guillermo; Noel Milpied; Niels Murawski; Anders Osterborg; Ruth Pettengell
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
The lancet oncology 2011;12(11):1013-22.
2011: Fernando Roncolato; Pier Luigi Zinzani; Anna Gazzola; Stefano A Pileri; Pier Paolo Piccaluga
Targeted molecular therapy in peripheral T-cell lymphomas.
Expert review of hematology 2011;4(5):551-62.
2011: Pier Luigi Zinzani; Pier Paolo Piccaluga
Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.
Current oncology reports 2011;13(5):407-15.
2011: Karin Hohloch; Woijciech Jurczak; Werner Linkesch; Cheolwon Suh; Roberto Cacchione; Angelika Bischof Delaloye; Jose Gómez-Codina; Christiane Windemuth-Kieselbach; Pier Luigi Zinzani; Lorenz Trümper
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the International Radioimmunotherapy Network.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(9):1354-60.
2011: Kerry J Savage; Pier Luigi Zinzani; Andrés J M Ferreri; Stefano A Pileri
Peripheral T-cell lymphoma--not otherwise specified.
Critical reviews in oncology/hematology 2011;79(3):321-9.
2011: Cinzia Pellegrini; Stefano Pileri; Federica Quirini; Pietro Ruggieri; Vittorio Stefoni; Lisa Argnani; Michele Baccarani; Alessandro Broccoli; Enrico Derenzini; Letizia Gandolfi; Mario Mercuri; Pier Luigi Zinzani
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients.
Clinical lymphoma, myeloma & leukemia 2011;11(4):321-5.
2011: Juliano J Cerci; Artur M N Coutinho; Dominique Delbeke; Stefano Fanti; Camila C G Linardi; Felipe A Pitela; Luis Fernando Pracchia; José Soares; evelinda trindade; Lucia Zanoni; Pier Luigi Zinzani; Valeria Buccheri; Monica Celli; José Cláudio Meneghetti
Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
Clinical lymphoma, myeloma & leukemia 2011;11(4):314-20.
2011: Bertrand Coiffier; Michael Crump; Sven de Vos; Yusri A Elsayed; Christopher Enny; Dixie Esseltine; Xiaonan Hong; Jiri Mayer; Fritz Offner; Evgenii A Osmanov; Simon Rule; Adriana Scheliga; Ofer Shpilberg; Adriana Teixeira; Panteli Theocharous; Helgi van de Velde; Jan Walewski; Eugene Zhu; Pier Luigi Zinzani
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.
The lancet oncology 2011;12(8):773-84.
2011: Pier Luigi Zinzani; Lisa Argnani; Emilio Berti; Alessandro Broccoli; Enrico Derenzini; Letizia Gandolfi; Cinzia Pellegrini; Stefano Pileri; Federica Quirini; Vittorio Stefoni; Michele Baccarani
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.
Leukemia & lymphoma 2011;52(8):1585-8.
2011: Simonetta Viviani; Francesco Zaja; Pier Luigi Zinzani; Delia Rota Scalabrini; Gianni Bonadonna; Valeria Bonfante; Ercole Brusamolino; Andrea Gallamini; ALESSANDRO MASSIMO GIANNI; Manuel Gotti; Alessandro Levis; Anna Marina Liberati; Enrico M Pogliani; Patrizia Pregno; Alessandro Pulsoni; Alessandro Rambaldi; Andrea Rossi; Giorgina Specchia; Pinuccia Valagussa; Umberto Vitolo
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
The New England journal of medicine 2011;365(3):203-12.
2011: Andrés J M Ferreri; Pier Luigi Zinzani; Silvia Govi; Stefano A Pileri
Enteropathy-associated T-cell lymphoma.
Critical reviews in oncology/hematology 2011;79(1):84-90.
2011: Francine M Foss; Randy D Gascoyne; Steven T Rosen; Julie M Vose; Pier Luigi Zinzani; Kensei Tobinai
Peripheral T-cell lymphoma.
Blood 2011;117(25):6756-67.
2011: Owen A O'Connor; Barbara Pro; Lauren Pinter-Brown; Nancy Bartlett; Leslie Popplewell; Bertrand Coiffier; Mary Jo Lechowicz; Kerry J Savage; Andrei R Shustov; Christian Gisselbrecht; Eric Jacobsen; Pier Luigi Zinzani; Richard Furman; Andre Goy; Corinne Haioun; Michael Crump; Jasmine M Zain; Eric Hsi; Adam Boyd; Steven Horwitz
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1182-9.
2011: Pier Luigi Zinzani; Letizia Gandolfi; Alessandro Broccoli; Lisa Argnani; Stefano Fanti; Cinzia Pellegrini; Vittorio Stefoni; Enrico Derenzini; Federica Quirini; Michele Baccarani
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Cancer 2011;117(5):1010-8.
2011: Anna Gazzola; Maria Teresa Sista; Claudio Agostinelli; Simona Righi; Maria Rosaria Sapienza; Claudia Mannu; Maura Rossi; Francesco Bacci; Elena Sabattini; Philip Thomas Went; Pier Luigi Zinzani; Stefano A Pileri; Pier Paolo Piccaluga
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified.
Journal of clinical pathology 2011;64(1):83-7.
2010: Pier Luigi Zinzani; Alessandro Broccoli; Vittorio Stefoni; Gerardo Musuraca; Elisabetta Abruzzese; Amalia De Renzo; Maria Cantonetti; Francesco Bacci; Michele Baccarani; Stefano A Pileri
Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.
Cancer 2010;116(24):5667-75.
2010: Pier Luigi Zinzani; Cinzia Pellegrini; Vittorio Stefoni; Enrico Derenzini; Letizia Gandolfi; Alessandro Broccoli; Lisa Argnani; Federica Quirini; Stefano Pileri; Michele Baccarani
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Cancer 2010;116(20):4788-92.
2010: E Lopci; I Santi; E Derenzini; C Fonti; G Savelli; F Bertagna; M Bellò; B Botto; D Huglo; F Morschhauser; Pier Luigi Zinzani; S Fanti
FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(9):1877-83.
2010: Pier Luigi Zinzani; Letizia Gandolfi; Vittorio Stefoni; Stefano Fanti; Mariapaola Fina; Cinzia Pellegrini; Gian Carlo Montini; Enrico Derenzini; Alessandro Broccoli; Lisa Argnani; Stefano Pileri; Michele Baccarani
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome.
Clinical lymphoma, myeloma & leukemia 2010;10(4):258-61.
2010: Pier Luigi Zinzani; Giuseppe Rossi; Silvia Franceschetti; Barbara Botto; Alice Di Rocco; Maria Giuseppina Cabras; Maria Concetta Petti; Vittorio Stefoni; Alessandro Broccoli; Stefano Fanti; Cinzia Pellegrini; Gian Carlo Montini; Letizia Gandolfi; Enrico Derenzini; Lisa Argnani; Mariapaola Fina; Alessandra Tucci; Chiara Bottelli; Stefano Pileri; Michele Baccarani
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):3998-4004.
2010: Enrica Marchi; Luca Paoluzzi; Luigi Scotto; Venkatraman E Seshan; Jasmine M Zain; Pier Luigi Zinzani; Owen A O'Connor
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(14):3648-58.
2010: Enrico Derenzini; Mariapaola Fina; Vittorio Stefoni; Cinzia Pellegrini; F Venturini; A Broccoli; L Gandolfi; Stefano Pileri; Stefano Fanti; E Lopci; paolo castellucci; C Agostinelli; M Baccarani; Pier Luigi Zinzani
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1173-8.
2010: Pier Luigi Zinzani
High-dose therapy and stem cell transplantation.
Seminars in hematology 2010;47 Suppl 1():S15-7.
2010: Pier Luigi Zinzani; F Venturini; Vittorio Stefoni; Mariapaola Fina; Cinzia Pellegrini; Enrico Derenzini; L Gandolfi; A Broccoli; L Argnani; F Quirini; Stefano Pileri; Michele Baccarani
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(4):860-3.
2010: Umberto Vitolo; Giovanni Barosi; Stefano Fanti; ALESSANDRO MASSIMO GIANNI; Maurizio Martelli; Mario Petrini; Pier Luigi Zinzani; Sante Tura
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.
American journal of hematology 2010;85(2):147-55.
2009: Enrico Derenzini; Vittorio Stefoni; Cinzia Pellegrini; Mariapaola Fina; Alessandro Broccoli; Filippo Venturini; Letizia Gandolfi; Stefano A Pileri; Maurizio Martelli; Maria Concetta Petti; Alessio Perrotti; Amalia De Renzo; Francesco Zaja; Michele Baccarani; Pier Luigi Zinzani
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma.
Leukemia & lymphoma 2009;50(11):1824-9.
2009: Pier Paolo Piccaluga; Maria Rosaria Sapienza; Claudio Agostinelli; Carlo Sagramoso; Claudia Mannu; Elena Sabattini; Pier Luigi Zinzani; Stefano A Pileri
Biology and treatment of follicular lymphoma.
Expert review of hematology 2009;2(5):533-47.
2009: Pier Luigi Zinzani; Vittorio Stefoni; Erica Finolezzi; Ercole Brusamolino; Maria Giuseppina Cabras; Annalisa Chiappella; Flavia Salvi; Andrea Rossi; Alessandro Broccoli; Maurizio Martelli
Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Clinical lymphoma & myeloma 2009;9(5):381-5.
2009: Michael R Grever; Pier Luigi Zinzani
Long-term follow-up studies in hairy cell leukemia.
Leukemia & lymphoma 2009;50 Suppl 1():23-6.
2009: Vittorio Stefoni; Alessandro Broccoli; Cinzia Pellegrini; Enrico Derenzini; Mariapaola Fina; Pier Luigi Zinzani
CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission.
Journal of neuro-oncology 2009;95(1):135-9.
2009: Francesco Crea; Elisa Giovannetti; Pier Luigi Zinzani; Romano Danesi
Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.
Critical reviews in oncology/hematology 2009;72(1):21-44.
2009: Pier Luigi Zinzani; Vittorio Stefoni; Monica Tani; Stefano Fanti; Gerardo Musuraca; paolo castellucci; Enrica Marchi; Mariapaola Fina; Valentina Ambrosini; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Gian Carlo Montini; Alessandro Broccoli; Francesco Bacci; Stefano Pileri; Michele Baccarani
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1781-7.
2009: Ercole Brusamolino; Andrea Bacigalupo; Giovanni Barosi; Giampaolo Biti; Paolo G Gobbi; Alessandro Levis; Monia Marchetti; Armando Santoro; Pier Luigi Zinzani; Sante Tura
Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
Haematologica 2009;94(4):550-65.
2009: Francesca Palandri; Enrico Derenzini; Emanuela Ottaviani; Nicola Polverelli; Lucia Catani; Federica Salmi; Elena Sabattini; Francesco Bacci; Pier Luigi Zinzani; Michele Baccarani; Nicola Vianelli
Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience.
Leukemia & lymphoma 2009;50(3):481-4.
2008: Patrizia Tosi; Giovanni Barosi; Carlo Lazzaro; Vincenzo Liso; Monia Marchetti; Enrica Morra; Andrea Pession; Giovanni Rosti; Antonio Santoro; Pier Luigi Zinzani; Sante Tura
Consensus conference on the management of tumor lysis syndrome.
Haematologica 2008;93(12):1877-85.
2008: Franck Morschhauser; John Radford; Achiel Van Hoof; Umberto Vitolo; Pierre Soubeyran; Hervé Tilly; Peter C Huijgens; Arne Kolstad; Francesco d'Amore; Marcos Gonzalez Diaz; Mario Petrini; Catherine Sebban; Pier Luigi Zinzani; Marinus H J van Oers; Wim van Putten; Angelika Bischof Delaloye; Ama Rohatiner; Gilles SALLES; Jens Kuhlmann; Anton Hagenbeek
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5156-64.
2008: Enrico Derenzini; Gerardo Musuraca; Stefano Fanti; Vittorio Stefoni; Monica Tani; Lapo Alinari; Filippo Venturini; Letizia Gandolfi; Michele Baccarani; Pier Luigi Zinzani
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Cancer 2008;113(9):2496-503.
2008: Pier Luigi Zinzani; Maurizio Martelli; Venerino Poletti; Umberto Vitolo; Paolo G Gobbi; Tommaso Chisesi; Giovanni Barosi; Andrés J M Ferreri; Monia Marchetti; Nicola Pimpinelli; Sante Tura
Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2008;93(9):1364-71.
2008: Charoula S Tsamita; Arber Golemi; Lapci Egesta; paolo castellucci; Cristina Nanni; Vittorio Stefoni; Gaia Grassetto; Domenico Rubello; Monica Tani; Pier Luigi Zinzani; Stefano Fanti
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET.
Nuclear medicine communications 2008;29(8):705-10.
2008: Pier Paolo Piccaluga; Andrea Califano; Ulf Klein; Claudio Agostinelli; Beatriz Bellosillo; Eva Gimeno; Sergi Serrano; Francisco Solè; Yonghui Zang; Brunangelo Falini; Pier Luigi Zinzani; Stefano A Pileri
Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Haematologica 2008;93(7):1033-8.
2008: Stefano Fanti; paolo castellucci; Vittorio Stefoni; Cristina Nanni; Monica Tani; Domenico Rubello; Valentina Ambrosini; Pier Luigi Zinzani; Roberto Franchi
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.
Annals of nuclear medicine 2008;22(5):429-32.
2008: Michael Pfreundschuh; Anthony Ho; Eva Cavallin-Stahl; Max Wolf; Ruth Pettengell; Ingrid Vasova; Andrew Belch; Jan Walewski; Pier Luigi Zinzani; Walter Mingrone; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Claudia Corrado; Adriana Scheliga; Markus Loeffler; Evelyn Kuhnt
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
The lancet oncology 2008;9(5):435-44.
2008: Pier Luigi Zinzani; Monica Tani; Alessandro Pulsoni; marco gobbi; Alessio Perotti; Stefano De Luca; Alberto Fabbri; Alfonso Zaccaria; Maria Teresa Voso; Patrizia Fattori; Luciano Guardigni; Sonia Ronconi; Maria Giuseppina Cabras; Luigi Rigacci; Amalia De Renzo; Enrica Marchi; Vittorio Stefoni; Mariapaola Fina; Cinzia Pellegrini; Gerardo Musuraca; Enrico Derenzini; Stefano Pileri; Stefano Fanti; Pier Paolo Piccaluga; Michele Baccarani
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
The lancet oncology 2008;9(4):352-8.
2008: Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Vittorio Stefoni; Gerardo Musuraca; paolo castellucci; Enrica Marchi; Mohsen Farsad; Mariapaola Fina; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Antonio de Vivo; Francesco Bacci; Stefano Pileri; Michele Baccarani
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):769-73.
2008: Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Vittorio Stefoni; Gerardo Musuraca; Umberto Vitolo; Alessio Perrotti; Mariapaola Fina; Enrico Derenzini; Michele Baccarani
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
Cancer 2008;112(4):856-62.
2008: Pier Luigi Zinzani; Francesco d'Amore; Emilio Bombardieri; Caroline Brammer; José Gómez Codina; Tim Illidge; Wojciech Jurczak; Werner Linkesch; Franck Morschhauser; Elisabeth Vandenberghe; Achiel Van Hoof
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European journal of cancer (Oxford, England : 1990) 2008;44(3):366-73.
2008: Pier Luigi Zinzani; Andrés J M Ferreri; Lorenzo Cerroni
Mycosis fungoides.
Critical reviews in oncology/hematology 2008;65(2):172-82.
2008: Enrico Derenzini; Stefania Paolini; giovanni martinelli; Cristina Campidelli; Gian Luca Grazi; Carlo Calabrese; Pier Luigi Zinzani; Michele Baccarani
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge.
Leukemia & lymphoma 2008;49(1):159-62.
2007: Gianluca Brusa; Elisa Zuffa; Claudia M Hattinger; Massimo Serra; Daniel Remondini; Gastone Castellani; Simona Righi; Cristina Campidelli; Stefano Pileri; Pier Luigi Zinzani; Annalisa Gabriele; Manuela Mancini; Patrizia Corrado; Enza Barbieri; Maria Alessandra Santucci
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma.
Oncology reports 2007;18(6):1427-34.
2007: Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Antonino Carbone; Luca Fantoni; Sergio Ferrari; Anna Gazzola; Annunziata Gloghini; Simona Righi; Maura Rossi; Enrico Tagliafico; Pier Luigi Zinzani; Simona Zupo; Michele Baccarani; Stefano A Pileri
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
Cancer research 2007;67(22):10703-10.
2007: Pier Luigi Zinzani; Venerino Poletti; Maurizio Zompatori; Monica Tani; Lucia Spaggiari; Sara Tomassetti; Alessandro Broccoli; Enrico Derenzini; Michele Baccarani
Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma.
Clinical lymphoma & myeloma 2007;7(9):566-72.
2007: Mariapaola Fina; Monica Tani; Vittorio Stefoni; Gerardo Musuraca; Enrica Marchi; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Francesco Bacci; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.
Leukemia & lymphoma 2007;48(11):2167-71.
2007: Alessandro Isidori; Maria Rosa Motta; Monica Tani; Carolina Terragna; Pier Luigi Zinzani; Antonio Curti; Simonetta Rizzi; Simona Taioli; Valeria Giudice; Alessandra D'Addio; Gabriele Gugliotta; Roberto Conte; Michele Baccarani; Roberto M Lemoli
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1224-32.
2007: Pier Luigi Zinzani; Gerardo Musuraca; Monica Tani; Vittorio Stefoni; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Antonio de Vivo; Elena Sabattini; Stefano Pileri; Michele Baccarani
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4293-7.
2007: Franck Morschhauser; Timothy M Illidge; Damien Huglo; Giovanni Martinelli; Giovanni Paganelli; Pier Luigi Zinzani; Simon Rule; Anna Marina Liberati; Noël Milpied; Georg Hess; Harald Stein; Joachim Kalmus; Robert Marcus
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.
Blood 2007;110(1):54-8.
2007: Pier Luigi Zinzani; Monica Tani; Rocco Trisolini; Stefano Fanti; Vittorio Stefoni; Marco Alifano; paolo castellucci; Gerardo Musuraca; Giorgia Dalpiaz; Lapo Alinari; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; Mohsen Farsad; Alessandra Cancellieri; Annalisa Busca; Romeo Canini; Stefano Pileri; Michele Baccarani; Maurizio Boaron
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
Haematologica 2007;92(6):771-7.
2007: Elena Sabattini; Rocio Orduz; Cristina Campidelli; Pier Luigi Zinzani; Vincenzo Callea; Simona Zupo; Giovanna Cutrona; Fortunato Morabito; Manlio Ferrarini; Stefano Pileri
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.
Journal of clinical pathology 2007;60(6):627-32.
2007: Pier Paolo Piccaluga; Claudio Agostinelli; Simona Righi; Pier Luigi Zinzani; Stefano A Pileri
Expression of CD52 in peripheral T-cell lymphoma.
Haematologica 2007;92(4):566-7.
2007: Franck Morschhauser; Pier Luigi Zinzani; Michael Burgess; Lisette Sloots; Fadhela Bouafia; Charles Dumontet
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 2007;48(4):708-15.
2007: Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Maura Rossi; Katia Basso; Simona Zupo; Philip Thomas Went; Ulf Klein; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla-Favera; Stefano A Pileri
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.
The Journal of clinical investigation 2007;117(3):823-34.
2007: Stefano A Pileri; Stefano Ascani; m christina cox; Cristina Campidelli; Francesco Bacci; Milena Piccioli; Pier Paolo Piccaluga; Claudio Agostinelli; Sofia Asioli; Domenico Novero; M Bisceglia; Maurilio Ponzoni; A Gentile; P Rinaldi; V Franco; D Vincelli; Alessandro Pileri; R Gasbarra; Brunangelo Falini; Pier Luigi Zinzani; Michele Baccarani
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.
Leukemia 2007;21(2):340-50.
2007: Pier Luigi Zinzani; Gerardo Musuraca; Lapo Alinari; Stefano Fanti; Monica Tani; Vittorio Stefoni; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; paolo castellucci; Mohsen Farsad; Michele Baccarani
Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.
Clinical lymphoma & myeloma 2007;7(4):291-5.
2006: Maura Brugiatelli; Giuseppe Bandini; Giovanni Barosi; Francesco Lauria; Vincenzo Liso; Monia Marchetti; Francesca Romana Mauro; Giovanna Meloni; Pier Luigi Zinzani; Sante Tura
Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2006;91(12):1662-73.
2006: Lapo Alinari; paolo castellucci; Rebecca L Elstrom; Valentina Ambrosini; Vittorio Stefoni; Cristina Nanni; Arnold Berkowitz; Monica Tani; Mohsen Farsad; Roberto Franchi; Stefano Fanti; Pier Luigi Zinzani
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
Leukemia & lymphoma 2006;47(10):2096-101.
2006: Pier Luigi Zinzani
Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma.
Leukemia & lymphoma 2006;47(10):2013-4.
2006: Andreas Engert; Raoul Herbrecht; Armando Santoro; Pier Luigi Zinzani; Igor Gorbatchevsky
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.
Clinical lymphoma & myeloma 2006;7(2):152-4.
2006: Pier Luigi Zinzani
Salvage chemotherapy in follicular non-Hodgkin's lymphoma: focus on tolerability.
Clinical lymphoma & myeloma 2006;7(2):115-24.
2006: Sandra J Strauss; Franck Morschhauser; Juergen Rech; Roland Repp; Philippe Solal-Celigny; Pier Luigi Zinzani; Andreas Engert; Bertrand Coiffier; Dieter F Hoelzer; William A Wegener; Nick K W Teoh; David M Goldenberg; T Andrew Lister
Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3880-6.
2006: Pier Paolo Piccaluga; Ernesto Vigna; Angelo Placci; Claudio Agostinelli; Claudio Laterza; Cristina Papayannidis; Ornella Leone; giovanni martinelli; Pier Luigi Zinzani; Michele Baccarani; Stefano A Pileri
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.
British journal of haematology 2006;134(4):356.
2006: Giuseppe Marotta; Antonio Frassoldati; Pier Luigi Zinzani; Luciana Annino; Maura Brugiatelli; Achille Ambrosetti; Mariapia Lenoci; Massimo Federico; Robin Foa; Francesco Lauria
Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
European journal of haematology 2006;77(2):109-13.
2006: Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Lapo Alinari; Gerardo Musuraca; Enrica Marchi; Vittorio Stefoni; paolo castellucci; Mariapaola Fina; M Farshad; Stefano Pileri; Michele Baccarani
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(8):1296-300.
2006: Pier Luigi Zinzani
Primary gastric diffuse large-cell lymphoma.
Leukemia & lymphoma 2006;47(7):1201-2.
2006: Lapo Alinari; Valentina Ambrosini; paolo castellucci; Monica Tani; Vittorio Stefoni; Cristina Nanni; Mohsen Farsad; Domenico Rubello; Roberto Franchi; Pier Luigi Zinzani; Stefano Fanti
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients.
Leukemia & lymphoma 2006;47(6):1048-52.
2006: Stefania Lorenzini; Pietro Andreone; Annagiulia Gramenzi; C Morelli; Pier Luigi Zinzani; Gian Luca Grazi; Stefano Pileri; Michele Baccarani; Sante Tura; Mauro Bernardi
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases.
Transplantation proceedings 2006;38(5):1477-80.
2006: Philip Thomas Went; Claudio Agostinelli; Andrea Gallamini; Pier Paolo Piccaluga; Stefano Ascani; Elena Sabattini; Francesco Bacci; Brunangelo Falini; Teresio Motta; Marco Paulli; Tullio Artusi; Milena Piccioli; Pier Luigi Zinzani; Stefano A Pileri
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2472-9.
2006: Michael Pfreundschuh; Lorenz Trümper; Anders Osterborg; Ruth Pettengell; Marek Trneny; Kevin Imrie; David Ma; Devinder Gill; Jan Walewski; Pier Luigi Zinzani; Rolf Stahel; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Tuula Lehtinen; Armando López-Guillermo; Claudia Corrado; Adriana Scheliga; Noël Milpied; Myriam Mendila; Michelle Rashford; Evelyn Kuhnt; Markus Loeffler
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
The lancet oncology 2006;7(5):379-91.
2006: Pier Luigi Zinzani; Pietro Quaglino; Nicola Pimpinelli; Emilio Berti; Gianandrea Baliva; Serena Rupoli; Maurizio Martelli; Mauro Alaibac; Giovanni Borroni; Sergio Chimenti; Renato Alterini; Lapo Alinari; Maria Teresa Fierro; Nazario Cappello; Alessandro Pileri; Davide Soligo; Marco Paulli; Stefano Pileri; Marco Santucci; Maria Grazia Bernengo
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1376-82.
2006: Valentina Ambrosini; Domenico Rubello; paolo castellucci; Cristina Nanni; Mohsen Farsad; Pier Luigi Zinzani; Abass Alavi; Neda Tehranipour; Adil Al-Nahhas; Stefano Fanti
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
Nuclear medicine review. Central & Eastern Europe 2006;9(1):37-40.
2006: Giovanni Barosi; Angelo Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Corrado Tarella; Umberto Vitolo; Pier Luigi Zinzani; Sante Tura
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2006;91(1):96-103.
2005: Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Monica Tani; Enrica Marchi; Annalisa Gabriele; Mariapaola Fina; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
Leukemia & lymphoma 2005;46(12):1839-41.
2005: Enrica Marchi; Lapo Alinari; Monica Tani; Vittorio Stefoni; Nicola Pimpinelli; Emilio Berti; Livio Pagano; Maria Grazia Bernengo; Francesco Zaja; Serena Rupoli; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
Cancer 2005;104(11):2437-41.
2005: Marco Chilosi; Pier Luigi Zinzani; Venerino Poletti
Lymphoproliferative lung disorders.
Seminars in respiratory and critical care medicine 2005;26(5):490-501.
2005: Lapo Alinari; Gerardo Musuraca; Monica Tani; Vittorio Stefoni; Annalisa Gabriele; Enrica Marchi; Mariapaola Fina; Antonio de Vivo; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(10):1437-40.
2005: Pier Luigi Zinzani; Monica Tani; Lapo Alinari; Anna Lia Molinari; Vittorio Stefoni; Giuseppe Visani; Paolo Gentilini; Luciano Guardigni; Mariapaola Fina; Michele Baccarani
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
Leukemia & lymphoma 2005;46(10):1449-54.
2005: Monica Tani; Mariapaola Fina; Lapo Alinari; Vittorio Stefoni; Michele Baccarani; Pier Luigi Zinzani
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
Haematologica 2005;90(9):1283-4.
2005: Giovanni Barosi; Angelo Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Corrado Tarella; Umberto Vitolo; Pier Luigi Zinzani; Sante Tura
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation.
Haematologica 2005;90(9):1236-57.
2005: paolo castellucci; Cristina Nanni; Mohsen Farsad; Lapo Alinari; Pier Luigi Zinzani; Vittorio Stefoni; Giuseppe Battista; Daria Valentini; Cinzia Pettinato; Mario Marengo; Stefano Boschi; Romeo Canini; Michele Baccarani; Nino Monetti; Roberto Franchi; Lucia Rampin; Stefano Fanti; Domenico Rubello
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
Nuclear medicine communications 2005;26(8):689-94.
2005: paolo castellucci; Pier Luigi Zinzani; Michael Pourdehnad; Lapo Alinari; Cristina Nanni; Mohsen Farsad; Giuseppe Battista; Monica Tani; Vittorio Stefoni; Romeo Canini; Nino Monetti; Domenico Rubello; Abass Alavi; Roberto Franchi; Stefano Fanti
18F-FDG PET in malignant lymphoma: significance of positive findings.
European journal of nuclear medicine and molecular imaging 2005;32(7):749-56.
2005: Pier Paolo Piccaluga; Claudio Agostinelli; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla-Favera; Stefano A Pileri
Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified.
The lancet oncology 2005;6(6):440.
2005: Pier Luigi Zinzani; Lapo Alinari; Monica Tani; Mariapaola Fina; Stefano Pileri; Michele Baccarani
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
Haematologica 2005;90(5):702-3.
2005: Alessandro Rambaldi; Emanuela Carlotti; Elena Oldani; Irene Della Starza; Michele Baccarani; Sergio Cortelazzo; Francesco Lauria; Luca Arcaini; Enrica Morra; Alessandro Pulsoni; Luigi Rigacci; Maurizio Rupolo; Francesco Zaja; Pier Luigi Zinzani; Tiziano Barbui; Robin Foa
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.
Blood 2005;105(9):3428-33.
2005: Pier Luigi Zinzani; Stephan Dirnhofer; Elena Sabattini; Lapo Alinari; Pier Paolo Piccaluga; Vittorio Stefoni; Monica Tani; Gerardo Musuraca; Enrica Marchi; Brunangelo Falini; Michele Baccarani; Stefano A Pileri
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
Haematologica 2005;90(3):341-7.
2005: Stefano A Pileri; Pier Paolo Piccaluga; Elena Sabattini; Pier Luigi Zinzani
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis.
Haematologica 2005;90(3):293.
2005: Pier Luigi Zinzani
Lymphoma: diagnosis, staging, natural history, and treatment strategies.
Seminars in oncology 2005;32(1 Suppl 1):S4-10.
2005: Alessandro Isidori; Monica Tani; Francesca Bonifazi; Pier Luigi Zinzani; Antonio Curti; Maria Rosa Motta; Simonetta Rizzi; Valeria Giudice; Oriana Farese; Manuela Rovito; Lapo Alinari; Roberto Conte; Michele Baccarani; Roberto M Lemoli
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
Haematologica 2005;90(2):225-31.
2005: Fredrick Hagemeister; Fernando Cabanillas; Morton Coleman; Stephanie A Gregory; Pier Luigi Zinzani
The role of mitoxantrone in the treatment of indolent lymphomas.
The oncologist 2005;10(2):150-9.
2005: Pier Luigi Zinzani
Autologous hematopoietic stem cell transplantation in Non-Hodgkin's lymphomas.
Acta haematologica 2005;114(4):255-9.
2005: Emanuele Zucca; Pier Luigi Zinzani
Understanding the group of peripheral T-cell lymphomas, unspecified.
Current hematology reports 2005;4(1):23-30.
2005: Pier Luigi Zinzani; Lapo Alinari; Vittorio Stefoni; Antonio Loffredo; Patrizia Pichierri; ennio polito
Rituximab in primary conjunctiva lymphoma.
Leukemia research 2005;29(1):107-8.
2004: Paolo G Gobbi; Chiara Broglia; Giuseppe Di Giulio; Monica Mantelli; Paola Anselmo; Francesco Merli; Pier Luigi Zinzani; Gabriele Rossi; Vincenzo Callea; Emilio Iannitto; Marco Paulli; Lorena Garioni; Edoardo Ascari
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma.
Cancer 2004;101(8):1824-34.
2004: paolo castellucci; Pier Luigi Zinzani; Cristina Nanni; Mohsen Farsad; Andrea Moretti; Lapo Alinari; Giuseppe Battista; Cinzia Pettinato; Mario Marengo; Stefano Boschi; Romeo Canini; Michele Baccarani; Nino Monetti; Stefano Fanti
18F-FDG PET early after radiotherapy in lymphoma patients.
Cancer biotherapy & radiopharmaceuticals 2004;19(5):606-12.
2004: Pier Luigi Zinzani; Alessandro Pulsoni; Paolo Gentilini; Giuseppe Visani; Alessio Perrotti; Anna Lia Molinari; Luciano Guardigni; Monica Tani; Nicoletta Villivà; Vittorio Stefoni; Lapo Alinari; Maurizio Martelli; Francesca Bonifazi; Stefano Pileri; Sante Tura; Michele Baccarani
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2004;45(9):1815-9.
2004: Pier Luigi Zinzani; Stefano Fanti; Giuseppe Battista; Monica Tani; paolo castellucci; Vittorio Stefoni; Lapo Alinari; Mohsen Farsad; Gerardo Musuraca; Annalisa Gabriele; Enrica Marchi; Cristina Nanni; Romeo Canini; Nino Monetti; Michele Baccarani
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
British journal of cancer 2004;91(5):850-4.
2004: Teresa Marafioti; Cristina Mancini; Stefano Ascani; Elena Sabattini; Pier Luigi Zinzani; Michela Pozzobon; Karen Pulford; Brunangelo Falini; Elaine S Jaffe; Hans Konrad Müller-Hermelink; David Y Mason; Stefano A Pileri
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Haematologica 2004;89(8):957-64.
2004: Stefano A Pileri; Elena Sabattini; Claudio Agostinelli; Laura Bodega; Maura Rossi; Pier Luigi Zinzani; Teresa Marafioti
Histopathology of B-cell chronic lymphocytic leukemia.
Hematology/oncology clinics of North America 2004;18(4):807-26, viii.
2004: Enza Barbieri; Silvia Cammelli; Floranna Mauro; Francesco Perini; Alberto Cazzola; Stefano Neri; Feisal Bunkheila; Stefano Ferrari; Vladimiro Brandoli; Pier Luigi Zinzani; Mario Mercuri; Gaetano Bacci
Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
International journal of radiation oncology, biology, physics 2004;59(3):760-4.
2004: Pier Luigi Zinzani; Alessandro Pulsoni; Alessio Perrotti; Simona Soverini; Francesco Zaja; Amalia De Renzo; Sergio Storti; Vito Michele Lauta; Luciano Guardigni; Paolo Gentilini; Alessandra Tucci; Anna Lia Molinari; marco gobbi; Brunangelo Falini; Patrizia Fattori; Fabrizio Ciccone; Lapo Alinari; Maurizio Martelli; Stefano Pileri; Sante Tura; Michele Baccarani
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2654-61.
2004: Letizia Polito; Andrea Bolognesi; Pier Luigi Tazzari; Valentina Farini; Chiara Lubelli; Pier Luigi Zinzani; Francesca Ricci; Fiorenzo Stirpe
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.
Leukemia 2004;18(7):1215-22.
2004: Philip Thomas Went; Stefano Ascani; Erik Strom; Sverre-Henning Brorson; Maurizio Musso; Pier Luigi Zinzani; Brunangelo Falini; Stephan Dirnhofer; Stefano Pileri
Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease.
The lancet oncology 2004;5(6):381-3.
2004: Pier Luigi Zinzani; Vittorio Stefoni; Gerardo Musuraca; Monica Tani; Lapo Alinari; Annalisa Gabriele; Enrica Marchi; Stefano Pileri; Michele Baccarani
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer 2004;100(10):2190-4.
2004: Stefano Ascani; Elena Sabattini; Claudio Agostinelli; Pier Paolo Piccaluga; Pier Luigi Zinzani; Stefano A Pileri
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome.
Haematologica 2004;89(4):EIM07.
2004: Pier Luigi Zinzani; Monica Tani; Enrica Marchi; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Annalisa Gabriele; Stefano Pileri; Michele Baccarani
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
Haematologica 2004;89(3):309-13.
2004: Stefano Ascani; Philip Thomas Went; Anna Marina Liberati; Pier Paolo Piccaluga; Pier Luigi Zinzani; Stefano A Pileri
Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):953-4.
2004: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Filippo Gherlinzoni; Antonio de Vivo; Paolo Ricci; Giuseppe Bandini; Roberto M Lemoli; Maria Rosa Motta; Simonetta Rizzi; Valeria Guidice; Maurizio Zompatori; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Enrica Marchi; Simona Bassi; Roberto Conte; Stefano Pileri; Sante Tura; Michele Baccarani
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Leukemia & lymphoma 2004;45(2):321-6.
2004: Pier Luigi Zinzani
Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5 Suppl 1():S38-49.
2004: Stefano A Pileri; Pier Luigi Zinzani; Philip Thomas Went; Alessandro Pileri; Maurizio Bendandi
Indolent lymphoma: the pathologist's viewpoint.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(1):12-8.
2003: Francesca Romana Mauro; Pier Luigi Zinzani; Francesco Zaja; Massimo Gentile; Maria Luce Vegna; Vittorio Stefoni; Luciana Marin; Renato Fanin; Michele Baccarani; Sante Tura; Franco Mandelli
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Haematologica 2003;88(12):1348-57.
2003: Luigi Rigacci; Massimo Federico; Maurizio Martelli; Pier Luigi Zinzani; Luigi Cavanna; Giampiero Bellesi; Francesco Merli; Renato Alterini; Maria Teresa Petrucci; Monica Tani; Anna Marina Liberati; Umberto Vitolo; Vincenzo Pavone; Antonio Cuneo; Teodoro Chisesib; Maura Brugiatelli
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
Leukemia & lymphoma 2003;44(11):1911-7.
2003: Pier Luigi Zinzani
Complications of cytotoxic chemotherapy in older patients: focus on myelotoxicity in lymphomas.
Critical reviews in oncology/hematology 2003;48(Suppl):S27-31.
2003: Pier Luigi Zinzani; Vittorio Stefoni; Lapo Alinari; Nicola Vianelli; Michele Baccarani
Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Leukemia & lymphoma 2003;44(9):1637-8.
2003: Pier Luigi Zinzani; Monica Tani; Enza Barbieri; Vittorio Stefoni; Lapo Alinari; Michele Baccarani
Utility of surgical resection with or without radiation therapy in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Haematologica 2003;88(7):830-1.
2003: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Venerino Poletti; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Francesca Bonifazi; Stefano Pileri; Sante Tura; Michele Baccarani
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients.
Leukemia & lymphoma 2003;44(5):821-4.
2003: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Filippo Gherlinzoni; Antonio de Vivo; Paolo Ricci; Giuseppe Bandini; Roberto M Lemoli; Maria Rosa Motta; Simonetta Rizzi; Valeria Giudice; Maurizio Zompatori; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Simona Bassi; Roberto Conte; Stefano Pileri; Sante Tura; Michele Baccarani
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.
Haematologica 2003;88(5):522-8.
2003: Pier Luigi Zinzani; Monica Tani; Lapo Alinari; Vittorio Stefoni; Michele Baccarani
Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
Leukemia research 2003;27(5):465-6.
2003: Pier Luigi Zinzani; Lapo Alinari; Vittorio Stefoni; Monica Tani; Michele Baccarani
Bilateral primary breast lymphoma: a case of local recurrence.
Leukemia & lymphoma 2003;44(4):737-8.
2003: Maurizio Martelli; Filippo Gherlinzoni; Amalia De Renzo; Pier Luigi Zinzani; Antonio de Vivo; Maria Cantonetti; Brunangelo Falini; Sergio Storti; Giovanna Meloni; Manuela Rizzo; Anna Lia Molinari; Francesco Lauria; Luciano Moretti; Vito Michele Lauta; Patrizio Mazza; Luciano Guardigni; Edoardo Pescarmona; Stefano A Pileri; Franco Mandelli; Sante Tura
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1255-62.
2003: Emanuele Zucca; Annarita Conconi; Ennio Pedrinis; Sergio Cortelazzo; Teresio Motta; Mary K Gospodarowicz; Bruce J Patterson; Andrés J M Ferreri; Maurilio Ponzoni; liliana devizzi; Roberto Giardini; Graziella Pinotti; Carlo Capella; Pier Luigi Zinzani; Stefano Pileri; Armando López-Guillermo; Elias Campo; Achille Ambrosetti; Luca Baldini; Franco Cavalli
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Blood 2003;101(7):2489-95.
2003: Pier Luigi Zinzani; Giovanna Carrillo; Stefano Ascani; Enza Barbieri; Monica Tani; Marco Paulli; Vittorio Stefoni; Elena Sabattini; Lapo Alinari; Roberto Binazzi; Sante Tura; Michele Baccarani; Stefano A Pileri
Primary bone lymphoma: experience with 52 patients.
Haematologica 2003;88(3):280-5.
2003: Teresa Marafioti; Stefano Ascani; Karen Pulford; Elena Sabattini; Milena Piccioli; Margaret Jones; Pier Luigi Zinzani; Georges Delsol; David Y Mason; Stefano A Pileri
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.
The American journal of pathology 2003;162(3):861-71.
2003: Lucia Loni; Filippo de Braud; Pier Luigi Zinzani; Romano Danesi
Pharmacogenetics and proteomics of anticancer drugs in non-Hodgkin's lymphoma.
Leukemia & lymphoma 2003;44 Suppl 3():S115-22.
2003: Stefano A Pileri; Pier Luigi Zinzani; Gianluca Gaidano; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Elena Sabattini; Stefano Ascani; Maura Rossi; Franco Cavalli
Pathobiology of primary mediastinal B-cell lymphoma.
Leukemia & lymphoma 2003;44 Suppl 3():S21-6.
2003: Myron S Czuczman; Pier Luigi Zinzani
The first International Workshop on Non-Hodgkin's Lymphoma: taking a close look at current issues and future developments.
Leukemia & lymphoma 2003;44 Suppl 3():S1-4.
2003: Pier Luigi Zinzani
Traditional treatment approaches in B-cell non-Hodgkin's lymphoma.
Leukemia & lymphoma 2003;44 Suppl 4():S6-14.
2003: Pier Luigi Zinzani
Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14 Suppl 1():i43-5.
2003: Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
The American journal of pathology 2003;162(1):243-53.
2002: Stefano Aldo Pileri; Stefano Ascani; Pier Luigi Zinzani; Gianluca Gaidano; Milena Piccioli; Maura Rossi; Pier Paolo Piccaluga; Teresa Marafioti; Alessandro Pileri; Roberta Pacini; Brunangelo Falini; Elena Sabattini
Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach.
Haematologica 2002;87(12):ECR40.
2002: Bertrand Coiffier; Michael Pfreundschuh; Rolf Stahel; Julie Vose; Pier Luigi Zinzani
Aggressive lymphoma: improving treatment outcome with rituximab.
Anti-cancer drugs 2002;13 Suppl 2():S43-50.
2002: Giancarlo Caletti; Pier Luigi Zinzani; Pietro Fusaroli; E Buscarini; F Parente; Telemaco Federici; Sergio Peyre; Claudio Giovanni De Angelis; G Bonanno; Thomas Togliani; Stefano Pileri; Sante Tura
The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Alimentary pharmacology & therapeutics 2002;16(10):1715-22.
2002: Pier Luigi Zinzani
Non-Hodgkin's lymphoma: the evolving role of purine analogues.
Best practice & research. Clinical haematology 2002;15(3):505-16.
2002: Pier Luigi Zinzani; Filippo Gherlinzoni; Sergio Storti; Alfonso Zaccaria; E Pavone; Luciano Moretti; Paolo Gentilini; Luciano Guardigni; Amalia De Renzo; Patrizia Fattori; Brunangelo Falini; Vito Michele Lauta; D Mannina; Francesco Zaja; Patrizio Mazza; Ettore Volpe; Francesco Lauria; E Aitini; Fabrizio Ciccone; Monica Tani; Vittorio Stefoni; Lapo Alinari; Michele Baccarani; Sante Tura
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1364-9.
2002: Stefano A Pileri; Elena Sabattini; Pasquale Rosito; Pier Luigi Zinzani; Stefano Ascani; G Fraternali Orcioni; Barbara Gamberi; Milena Piccioli; D Vivenza; Brunangelo Falini; Gianluca Gaidano
Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics.
Journal of clinical pathology 2002;55(9):684-8.
2002: Pier Luigi Zinzani; Monica Tani; Vittorio Stefoni; Pier Paolo Piccaluga; Michele Baccarani; Stefano Ascani; Stefano Pileri
From chronic lymphocytic leukemia to Hodgkin's disease: a case of prognostically favorable transformation.
Leukemia research 2002;26(8):775-6.
2002: Pier Luigi Zinzani; Monica Tani; Anna Lia Molinari; Vittorio Stefoni; Elisa Zuffa; Lapo Alinari; Annalisa Gabriele; Francesca Bonifazi; Marzia Salvucci; Sante Tura; Michele Baccarani
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Haematologica 2002;87(8):816-21.
2002: Sergio Cortelazzo; Andrea Rossi; Elena Oldani; Teresio Motta; Roberto Giardini; Pier Luigi Zinzani; Emanuele Zucca; Henry Gomez; Andrés J M Ferreri; Graziella Pinotti; Claudio Chini; liliana devizzi; ALESSANDRO MASSIMO GIANNI; Franco Cavalli; Tiziano Barbui
The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies.
British journal of haematology 2002;118(1):218-28.
2002: Pier Luigi Zinzani; Franca Chierichetti; Maurizio Zompatori; Monica Tani; Vittorio Stefoni; G Garraffa; P Albertini; Lapo Alinari; G Ferlin; Michele Baccarani; Sante Tura
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
Leukemia & lymphoma 2002;43(6):1239-43.
2002: Hongxiang Liu; Hongtao Ye; Agnès Ruskone-Fourmestraux; Daphne De Jong; Stefano Pileri; Christian Thiede; Anne Lavergne; Henk Boot; Giancarlo Caletti; Thomas Wündisch; Thierry Molina; Babs G Taal; Sabattini Elena; Togliani Thomas; Pier Luigi Zinzani; Andreas Neubauer; Manfred Stolte; Rifat A Hamoudi; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Gastroenterology 2002;122(5):1286-94.
2002: Stefano A Pileri; Stefano Ascani; Lorenzo Leoncini; Elena Sabattini; Pier Luigi Zinzani; Pier Paolo Piccaluga; A Pileri; M Giunti; B Falini; GB Bolis; H Stein
Hodgkin's lymphoma: the pathologist's viewpoint.
Journal of clinical pathology 2002;55(3):162-76.
2002: Massimo Federico; Pier Luigi Zinzani; Antonio Frassoldati; Marco Vinceti; Alessia Modè; Luciana Annino; Teodoro Chisesi; Guido Pagnucco; Rosangela Invernizzi; Mauro Spriano; Luigi Resegotti; Maurizio Bendandi; Eugenio E Damasio
Risk of second cancer in patients with hairy cell leukemia: long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):638-46.
2002: Alessandro Rambaldi; Manuela Lazzari; Cristina Manzoni; Emanuela Carlotti; Luca Arcaini; Michele Baccarani; Tiziano Barbui; Carlo Bernasconi; Giuseppe Dastoli; Giovanna Fuga; Enrica Gamba; Livio Gargantini; Valter Gattei; Francesco Lauria; Mario Lazzarino; Franco Mandelli; Enrica Morra; Alessandro Pulsoni; Michela Ribersani; Pier Luigi Rossi-Ferrini; Maurizio Rupolo; Sante Tura; Vittorina Zagonel; Francesco Zaja; Pier Luigi Zinzani; Gigliola Reato; Robin Foa
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.
Blood 2002;99(3):856-62.
2001: Pier Luigi Zinzani; Nino Monetti; Maurizio Zompatori; Vittorio Stefoni; Stefano Fanti; M Baccarani; S Tura
Importance of gallium scan restaging for curative treatment of mediastinal lymphomas.
Haematologica 2001;86(11):1229-30.
2001: Stefano A Pileri; Pier Luigi Zinzani; Stefano Ascani; Giulio Fraternali Orcioni; Barbara Gamberi; Milena Piccioli; Elena Sabattini; S Poggi; Pier Paolo Piccaluga; Brunangelo Falini
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: clinico-pathologic study of nine cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(10):1445-53.
2001: Francesco Lauria; Mariapia Lenoci; Luciana Annino; Donatella Raspadori; Giuseppe Marotta; Monica Bocchia; Francesco Forconi; Sara Gentili; M La Manda; S Marconcini; Monica Tozzi; Luca Baldini; Pier Luigi Zinzani; Robin Foà
Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
Haematologica 2001;86(10):1046-50.
2001: Pier Luigi Zinzani; Vittorio Stefoni; Monica Tani; Enza Barbieri; P Albertini; Ernesto Vigna; Filippo Gherlinzoni; Lapo Alinari; Andrea Galuppi; Stefano Pileri; L Babini; Sante Tura
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results.
Leukemia & lymphoma 2001;42(5):989-95.
2001: Stefano A Pileri; Fabio Facchetti; Stefano Ascani; Elena Sabattini; S Poggi; Milena Piccioli; Damiano Rondelli; F Vergoni; Pier Luigi Zinzani; Pier Paolo Piccaluga; Brunangelo Falini; P G Isaacson
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy.
The American journal of pathology 2001;159(3):915-24.
2001: cesare guglielmi; Maurizio Martelli; Massimo Federico; Pier Luigi Zinzani; Umberto Vitolo; Giampiero Bellesi; Gino Santini; Corrado Tarella; Francesco Zallio; Patrizia Pregno; Nicola Di Renzo; Luigi Resegotti
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
Haematologica 2001;86(9):941-50.
2001: Paolo G Gobbi; Pier Luigi Zinzani; Chiara Broglia; Mario Comelli; M Magagnoli; Massimo Federico; Francesco Merli; Emilio Iannitto; S Tura; Edoardo Ascari
Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.
Cancer 2001;91(8):1467-78.
2001: Pier Luigi Zinzani; Monica Tani; Vittorio Stefoni; P Albertini; Maurizio Bendandi; Filippo Gherlinzoni; Lapo Alinari; Ernesto Vigna; Sante Tura
Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.
Haematologica 2001;86(3):287-90.
2001: Pier Luigi Zinzani; Maurizio Martelli; Maurizio Bendandi; Amalia De Renzo; Alfonso Zaccaria; E Pavone; Monica Bocchia; Brunangelo Falini; marco gobbi; Filippo Gherlinzoni; Vittorio Stefoni; Monica Tani; Sante Tura
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Haematologica 2001;86(2):187-91.
2000: Stefano A Pileri; Stefano Ascani; Elena Sabattini; G Fraternali Orcioni; S Poggi; Milena Piccioli; Pier Paolo Piccaluga; Barbara Gamberi; Pier Luigi Zinzani; Lorenzo Leoncini; Brunangelo Falini
The pathologist's view point. Part II --aggressive lymphomas.
Haematologica 2000;85(12):1308-21.
2000: Stefano A Pileri; Stefano Ascani; Elena Sabattini; G Fraternali Orcioni; S Poggi; Milena Piccioli; Pier Paolo Piccaluga; Barbara Gamberi; Pier Luigi Zinzani; Lorenzo Leoncini; Brunangelo Falini
The pathologist's view point. Part I--indolent lymphomas.
Haematologica 2000;85(12):1291-307.
2000: Pier Luigi Zinzani; Maurizio Bendandi; M Magagnoli; P Albertini; Damiano Rondelli; Vittorio Stefoni; Monica Tani; Sante Tura
Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia.
Haematologica 2000;85(11):1135-9.
2000: Pier Luigi Zinzani; Maurizio Bendandi; Vittorio Stefoni; P Albertini; Filippo Gherlinzoni; Monica Tani; P P Piccaluga; Sante Tura
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.
Haematologica 2000;85(9):926-9.
2000: Pier Luigi Zinzani; M Magagnoli; Maurizio Bendandi; Monica Tani; Vittorio Stefoni; Claudia Cellini; S Poggi; Milena Piccioli; S Pileri; Sante Tura
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
Haematologica 2000;85(9):922-5.
2000: Pier Luigi Zinzani; M Magagnoli; Maurizio Bendandi; Enza Barbieri; Andrea Galuppi; Filippo Gherlinzoni; Monica Tani; P Albertini; Vittorio Stefoni; L Babini; Sante Tura
Efficacy of the VBM regimen in the treatment of elderly patients with Hodgkin's disease.
Haematologica 2000;85(7):729-32.
2000: Pier Luigi Zinzani; Giannandrea Baliva; M Magagnoli; Maurizio Bendandi; G Modugno; Filippo Gherlinzoni; Giulio Fraternali Orcioni; Stefano Ascani; R Simoni; Stefano A Pileri; Sante Tura
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2603-6.
2000: Pier Luigi Zinzani; M Magagnoli; Maurizio Bendandi; Filippo Gherlinzoni; Giulio Fraternali Orcioni; Claudia Cellini; Vittorio Stefoni; Stefano A Pileri; Sante Tura
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):363-5.
2000: Pier Luigi Zinzani; M Magagnoli; Luciano Moretti; Amalia De Renzo; R Battista; Alfonso Zaccaria; Luciano Guardigni; Patrizio Mazza; R Marra; F Ronconi; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; Paolo Gentilini; Fabrizio Ciccone; Claudia Cellini; Vittorio Stefoni; F Ricciuti; marco gobbi; Sante Tura
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):773-9.
2000: Massimo Federico; Umberto Vitolo; Pier Luigi Zinzani; Teodoro Chisesi; V Clò; Giampiero Bellesi; M Magagnoli; Marina Liberati; Carola Boccomini; P Niscola; V Pavone; A Cuneo; Gino Santini; Maura Brugiatelli; Luca Baldini; Luigi Rigacci; Luigi Resegotti
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.
Blood 2000;95(3):783-9.
1999: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Edoardo Pescarmona; Laura Scaramucci; Fioretta Palombi; Maurizio Bendandi; Maria Paola Martelli; Stefano Ascani; Giulio Fraternali Orcioni; Stefano A Pileri; Franco Mandelli; Sante Tura
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients.
Blood 1999;94(10):3289-93.
1999: Pier Luigi Zinzani; M Magagnoli; Luciano Moretti; R Battista; F Ronconi; Amalia De Renzo; Alfonso Zaccaria; Paolo Gentilini; Luciano Guardigni; Filippo Gherlinzoni; Claudia Cellini; Patrizia Fattori; Maurizio Bendandi; Monica Bocchia; E Aitini; Sante Tura
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.
Haematologica 1999;84(11):1002-6.
1999: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Francesco Zaja; Sergio Storti; E Pavone; Vito Michele Lauta; Amalia De Renzo; marco gobbi; Monica Bocchia; F Ronconi; Laura Scaramucci; Filippo Gherlinzoni; Fioretta Palombi; Maurizio Bendandi; Vittorio Stefoni; P Anticoli Borza; Claudia Cellini; Franco Mandelli; Sante Tura
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Haematologica 1999;84(11):996-1001.
1999: Pier Luigi Zinzani; M Magagnoli; Franca Chierichetti; Maurizio Zompatori; G Garraffa; Maurizio Bendandi; Filippo Gherlinzoni; Claudia Cellini; Vittorio Stefoni; G Ferlin; Sante Tura
The role of positron emission tomography (PET) in the management of lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(10):1181-4.
1999: Patrizia Tosi; Andrea Pellacani; Pier Luigi Zinzani; M Magagnoli; Giuseppe Visani; Sante Tura
In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells.
Haematologica 1999;84(9):794-8.
1999: Pier Luigi Zinzani; M Magagnoli; Roberto Franchi; Maurizio Zompatori; Giovanni P Frezza; R Galassi; Filippo Gherlinzoni; Maurizio Bendandi; P Albertini; Nino Monetti; Sante Tura
Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement.
Haematologica 1999;84(7):604-7.
1999: Pier Luigi Zinzani; G Corneli; Alessandra Cancellieri; M Magagnoli; Nicola Lacava; Filippo Gherlinzoni; Maurizio Bendandi; P Albertini; Giuseppe Baruzzi; Sante Tura; Maurizio Boaron
Core needle biopsy is effective in the initial diagnosis of mediastinal lymphoma.
Haematologica 1999;84(7):600-3.
1999: Pier Luigi Zinzani; Sergio Storti; Alfonso Zaccaria; Luciano Moretti; M Magagnoli; E Pavone; Paolo Gentilini; Luciano Guardigni; marco gobbi; Patrizia Fattori; Brunangelo Falini; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; Amalia De Renzo; Francesco Zaja; Patrizio Mazza; Ettore Volpe; Monica Bocchia; E Aitini; Michela Tabanelli; Giuseppe Leone; Sante Tura
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.
Blood 1999;94(1):33-8.
1999: Stefano Ascani; P Leoni; G Fraternali Orcioni; I Bearzi; Milena Piccioli; M Materazzi; Pier Luigi Zinzani; Filippo Gherlinzoni; Brunangelo Falini; Stefano A Pileri
T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):649-53.
1999: Pier Luigi Zinzani; M Magagnoli; Piero Galieni; Maurizio Martelli; Venerino Poletti; Francesco Zaja; S Molica; Alfonso Zaccaria; A M Cantonetti; Paolo Gentilini; Luciano Guardigni; Filippo Gherlinzoni; Michela Ribersani; Maurizio Bendandi; P Albertini; Sante Tura
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1254.
1999: Andrea Pellacani; Patrizia Tosi; Pier Luigi Zinzani; Emanuela Ottaviani; P Albertini; M Magagnoli; Sante Tura
Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells.
Leukemia & lymphoma 1999;33(1-2):147-53.
1999: Pier Luigi Zinzani; M Magagnoli; Giovanni P Frezza; G Prologo; Filippo Gherlinzoni; Maurizio Bendandi; P Albertini; L Babini; Roberto D'Alessandro; Sante Tura
Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience.
Leukemia & lymphoma 1999;32(5-6):571-6.
1999: Pier Luigi Zinzani; M Magagnoli; Giovanni P Frezza; Enza Barbieri; Filippo Gherlinzoni; Andrea Galuppi; Maurizio Bendandi; E Merla; P Albertini; L Babini; Sante Tura
ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease.
Leukemia & lymphoma 1999;32(5-6):553-9.
1999: Francesco Lauria; Monica Bocchia; Giuseppe Marotta; Donatella Raspadori; Pier Luigi Zinzani; Damiano Rondelli
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Haematologica 1999;84(1):22-5.
1998: Pier Luigi Zinzani; M Magagnoli; Maurizio Bendandi; Giulio Fraternali Orcioni; Filippo Gherlinzoni; P Albertini; Stefano A Pileri; Sante Tura
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(12):1351-3.
1998: Pier Luigi Zinzani; Antonio Colecchia; Davide Festi; M Magagnoli; Angela M V Larocca; Stefano Ascani; Maurizio Bendandi; Giulio Fraternali Orcioni; Filippo Gherlinzoni; P Albertini; Stefano A Pileri; Enrico Roda; Sante Tura
Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patients.
Haematologica 1998;83(11):989-92.
1998: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Alfonso Zaccaria; F Ronconi; Maria Cantonetti; Monica Bocchia; R Marra; marco gobbi; Brunangelo Falini; Filippo Gherlinzoni; Luciano Moretti; Amalia De Renzo; Patrizio Mazza; E Pavone; Elena Sabattini; A Amendola; Maurizio Bendandi; Stefano A Pileri; Franco Mandelli; Sante Tura
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Blood 1998;92(3):790-4.
1998: Pier Luigi Zinzani; M Magagnoli; Filippo Gherlinzoni; Maurizio Bendandi; P Albertini; E Merla; Sante Tura
To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single center.
Haematologica 1998;83(6):502-7.
1998: Pier Luigi Zinzani; Stefano Pileri; Maurizio Bendandi; M Buzzi; Elena Sabattini; Stefano Ascani; Filippo Gherlinzoni; M Magagnoli; P Albertini; Sante Tura
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1532-7.
1997: Stefano Ascani; Milena Piccioli; S Poggi; A Briskomatis; GB Bolis; F Liberati; R Frongillo; Cecilia Caramatti; G Fraternali Orcioni; Barbara Gamberi; Pier Luigi Zinzani; Stefano Lazzi; Lorenzo Leoncini; J O'Leary; Pier Paolo Piccaluga; Stefano A Pileri
Pyothorax-associated lymphoma: description of the first two cases detected in Italy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(11):1133-8.
1997: Pier Luigi Zinzani
Idarubicin in low-grade non-Hodgkin's lymphomas.
Haematologica 1997;82(5 Suppl):23-4.
1997: Pier Luigi Zinzani; M Magagnoli; Stefano Ascani; P Ricci; V Poletti; Filippo Gherlinzoni; Giovanni P Frezza; Maurizio Bendandi; C Stefanetti; E Merla; Stefano Pileri; Sante Tura
Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):883-6.
1997: Pier Luigi Zinzani; Maurizio Bendandi; M Magagnoli; Damiano Rondelli; Antonio de Vivo; Monica Benni; Elena Zamagni; Michele Cavo; Sante Tura
Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
European journal of haematology 1997;59(2):82-8.
1997: Patrizia Tosi; Pier Luigi Zinzani; Andrea Pellacani; Emanuela Ottaviani; M Magagnoli; Sante Tura
Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells.
Leukemia & lymphoma 1997;26(3-4):343-8.
1997: Stefano Ascani; Pier Luigi Zinzani; Filippo Gherlinzoni; Elena Sabattini; A Briskomatis; Antonio de Vivo; Milena Piccioli; G Fraternali Orcioni; Federica Pieri; A Goldoni; Pier Paolo Piccaluga; D Zallocco; R Burnelli; Lorenzo Leoncini; Brunangelo Falini; S Tura; Stefano A Pileri
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):583-92.
1997: Pier Luigi Zinzani; E Pavone; Sergio Storti; Luciano Moretti; Patrizia Fattori; Luciano Guardigni; Brunangelo Falini; marco gobbi; Paolo Gentilini; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; M Magagnoli; Silvia Venturi; E Aitini; Michela Tabanelli; Giuseppe Leone; V Liso; Sante Tura
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.
Blood 1997;89(11):3974-9.
1997: Pier Luigi Zinzani; M Magagnoli; G Pagliani; Maurizio Bendandi; Filippo Gherlinzoni; E Merla; M Salvucci; Sante Tura
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Haematologica 1997;82(3):305-8.
1997: Francesco Lauria; Damiano Rondelli; Pier Luigi Zinzani; Monica Bocchia; Giuseppe Marotta; M Salvucci; Donatella Raspadori; MA Ventura; S Birtolo; Francesco Forconi; Sante Tura
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Leukemia 1997;11(5):629-32.
1997: Pier Luigi Zinzani; Maurizio Bendandi; M Magagnoli; Filippo Gherlinzoni; E Merla; Sante Tura
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):379-83.
1997: Pier Luigi Zinzani; Francesco Lauria; M Salvucci; Damiano Rondelli; Donatella Raspadori; Maurizio Bendandi; M Magagnoli; Sante Tura
Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
Haematologica 1997;82(2):152-5.
1997: Francesco Lauria; Monica Bocchia; Giuseppe Marotta; Donatella Raspadori; Pier Luigi Zinzani; Damiano Rondelli
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
Blood 1997;89(5):1838-9.
1997: Damiano Rondelli; Francesco Lauria; Pier Luigi Zinzani; Donatella Raspadori; MA Ventura; Piero Galieni; S Birtolo; Francesco Forconi; Renato Algeri; Sante Tura
2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders.
European journal of haematology 1997;58(1):46-50.
1996: Pier Luigi Zinzani; Maurizio Bendandi; Giuseppe Visani; Filippo Gherlinzoni; Giovanni P Frezza; E Merla; Silvia Manfroi; Alessandro Gozzetti; Sante Tura
Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients.
Leukemia & lymphoma 1996;23(5-6):577-82.
1996: Pier Luigi Zinzani; C Baccini; Alfonso Zaccaria; Giuseppe Visani; M Buzzi; A Morelli; A L Molinari; M Salvucci; Maurizio Bendandi; D Rubboli; Filippo Gherlinzoni; R Zanchini; Sante Tura
Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma.
European journal of haematology 1996;57(5):335-40.
1996: Roberto M Lemoli; Gianantonio Rosti; Giuseppe Visani; Filippo Gherlinzoni; M C Miggiano; A Fortuna; Pier Luigi Zinzani; Sante Tura
Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3018-25.
1996: Francesco Lauria; Donatella Raspadori; MA Ventura; Damiano Rondelli; Pier Luigi Zinzani; Filippo Gherlinzoni; M C Miggiano; M Fiacchini; Gianantonio Rosti; Simonetta Rizzi; Sante Tura
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
Bone marrow transplantation 1996;18(1):79-85.
1996: Pier Luigi Zinzani; Maurizio Zompatori; Maurizio Bendandi; Giuseppe Battista; Stefano Fanti; Enza Barbieri; Filippo Gherlinzoni; M R Rimondi; Giovanni P Frezza; P Pisi; E Merla; Alessandro Gozzetti; Romeo Canini; Nino Monetti; L Babini; Sante Tura
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1996;22(1-2):131-5.
1996: giovanni martinelli; Pier Luigi Zinzani; P Farabegoli
Purine analogs (fludarabine and 2-chlorodeoxyadenosine) as apoptosis-inducing drugs in CML therapy.
Haematologica 1996;81(3):286-7.
1996: Giuseppe Visani; Patrizia Tosi; Pier Luigi Zinzani; Silvia Manfroi; Emanuela Ottaviani; A Cenacchi; P Carrara; Marino Clavio; marco gobbi; Sante Tura
FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects.
European journal of haematology 1996;56(5):308-12.
1996: Pier Luigi Zinzani; Maurizio Bendandi; Giovanni P Frezza; Filippo Gherlinzoni; E Merla; M Salvucci; M Magagnoli; L Babini; Sante Tura
Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients.
Leukemia & lymphoma 1996;21(3-4):311-6.
1996: Pier Luigi Zinzani; Maurizio Bendandi; Filippo Gherlinzoni; E Merla; Alessandro Gozzetti; Sante Tura
FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphoma.
Haematologica 1996;81(2):168-71.
1996: Giovanni P Frezza; Enza Barbieri; Pier Luigi Zinzani; L Babini; Sante Tura
Supradiaphragmatic early stage Hodgkin's disease: does mantle radiation therapy still have a role?
Haematologica 1996;81(2):138-42.
1996: Pier Luigi Zinzani; Filippo Gherlinzoni; Giancarlo Piovaccari; Giovanni P Frezza; Maurizio Bendandi; R M Ferretti; Enza Barbieri; M Fiacchini; L Babini; B Magnani; Sante Tura
Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients.
Haematologica 1996;81(2):132-7.
1995: Pier Luigi Zinzani; Giovanni P Frezza; Maurizio Bendandi; Enza Barbieri; Filippo Gherlinzoni; Stefano Neri; A Baldissera; M Salvucci; L Babini; Sante Tura
Primary gastric lymphoma: a clinical and therapeutic evaluation of 82 patients.
Leukemia & lymphoma 1995;19(5-6):461-6.
1995: Romeo Canini; Giuseppe Battista; Nino Monetti; P Pisi; Stefano Fanti; Pier Luigi Zinzani; Maurizio Zompatori; Maurizio Bendandi; Filippo Gherlinzoni; A Corinaldesi
[Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
La Radiologia medica 1995;90(4):448-56.
1995: Pier Luigi Zinzani; Maurizio Martelli; S Storti; Maurizio Musso; Maria Cantonetti; G Leone; A Cajozzo; G Papa; Emilio Iannitto; A Perrotti
Phase III comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1995;19(3-4):329-35.
1995: Pier Luigi Zinzani; Maurizio Bendandi; Sante Tura
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma.
European journal of haematology 1995;55(4):262-6.
1995: Pier Luigi Zinzani; Filippo Gherlinzoni; Maurizio Bendandi; Alfonso Zaccaria; E Aitini; M Salvucci; Sante Tura
Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
European journal of haematology 1995;54(2):120-3.
1995: Patrizio Mazza; Pier Luigi Zinzani; Maurizio Martelli; M Fiacchini; Monica Bocchia; S Pileri; Brunangelo Falini; M F Martelli; Sergio Amadori; G Papa
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
Leukemia & lymphoma 1995;16(5-6):457-63.
1994: Pier Luigi Zinzani; Enza Barbieri; Maurizio Bendandi; F Perini; Filippo Gherlinzoni; Stefano Neri; I Ammendolia; M Salvucci; L Babini; M Fiacchini
CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease.
Tumori 1994;80(6):438-42.
1994: Pier Luigi Zinzani; Patrizia Tosi; Giuseppe Visani; giovanni martinelli; P Farabegoli; M Buzzi; Emanuela Ottaviani; M Salvucci; Maurizio Bendandi; Alfonso Zaccaria
Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.
American journal of hematology 1994;47(4):301-6.
1994: M Truini; A Briskomatis; Elena Sabattini; S Poggi; Filippo Gherlinzoni; Pier Luigi Zinzani; Antonio de Vivo; Brunangelo Falini; S Pileri
[Anaplastic large-cell lymphoma. Conceptual and diagnostic assessment].
Pathologica 1994;86(6):589-601.
1994: Patrizia Tosi; Giuseppe Visani; Emanuela Ottaviani; S Manfori; Pier Luigi Zinzani; Sante Tura
Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells.
Leukemia 1994;8(12):2076-82.
1994: Pier Luigi Zinzani; Enza Barbieri; Giuseppe Visani; Filippo Gherlinzoni; F Perini; Stefano Neri; Maurizio Bendandi; I Ammendolia; M Salvucci; L Babini
Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
Haematologica 1994;79(6):508-12.
1994: Giuseppe Visani; Patrizia Tosi; Pier Luigi Zinzani; Silvia Manfroi; Emanuela Ottaviani; Nicoletta Testoni; Marino Clavio; A Cenacchi; B Gamberi; P Carrara
FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias.
Leukemia 1994;8(11):1842-6.
1994: Pier Luigi Zinzani; Filippo Gherlinzoni; Maurizio Bendandi; M Salvucci; Sante Tura
Adult Burkitt's lymphoma: clinical and prognostic evaluation of 20 patients.
Leukemia & lymphoma 1994;14(5-6):465-70.
1994: Pier Luigi Zinzani; Michela Tabanelli; Maurizio Bendandi; Sante Tura
Prolonged bone marrow aplasia of refractory prolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment.
European journal of haematology 1994;53(1):56-8.
1994: Sante Tura; Pier Luigi Zinzani
New target of chronic lymphocytic leukemia treatment.
Haematologica 1994;79(3):197-8.
1994: Pier Luigi Zinzani; Enza Barbieri; Filippo Gherlinzoni; Giovanni P Frezza; Patrizio Mazza; A Pica; I Ammendolia; Maurizio Bendandi; Stefano Neri; G Miniaci
Radiotherapy in early stage Hodgkin's disease.
Leukemia & lymphoma 1994;13(3-4):285-9.
1994: Pier Luigi Zinzani; M Buzzi; P Farabegoli; giovanni martinelli; Patrizia Tosi; Elisa Zuffa; Giuseppe Visani; Nicoletta Testoni; M Salvucci; Maurizio Bendandi
Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.
Haematologica 1994;79(2):127-31.
1994: Pier Luigi Zinzani; M Buzzi; P Farabegoli; Patrizia Tosi; A Fortuna; Giuseppe Visani; giovanni martinelli; Alfonso Zaccaria; Sante Tura
Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells.
Leukemia & lymphoma 1994;13(1-2):95-7.
1994: Giuseppe Visani; Patrizia Tosi; Pier Luigi Zinzani; Silvia Manfroi; Alfonso Zaccaria; Nicoletta Testoni; Roberto M Lemoli; Gianantonio Rosti; S Pelliconi; Sante Tura
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case report.
British journal of haematology 1994;86(2):394-6.
1994: Pier Luigi Zinzani; M G Levrero; Francesco Lauria; Damiano Rondelli; Francesco Zaja; D Russo; Renato Fanin; G De Rossi; F R Mauro; Maurizio Bendandi; Alessandro Gozzetti; Ferdinando Dianzani; Franco Mandelli; Sante Tura
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Haematologica 1994;79(1):55-60.
1993: Francesco Lauria; D Benfenati; Donatella Raspadori; Damiano Rondelli; Pier Luigi Zinzani; Sante Tura
High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Leukemia & lymphoma 1993;11(5-6):399-404.
1993: Pier Luigi Zinzani; Maurizio Bendandi; Filippo Gherlinzoni; Patrizio Mazza; M Salvucci; E Aitini; M C Miggiano; Alessandro Gozzetti; Sante Tura
VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly.
Haematologica 1993;78(6):378-82.
1993: Pier Luigi Zinzani; Francesco Lauria; Damiano Rondelli; D Benfenati; Donatella Raspadori; Monica Bocchia; Alessandro Gozzetti; Michele Cavo; T M Cirio; Francesco Zaja
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia.
European journal of haematology 1993;51(2):93-7.
1993: Pier Luigi Zinzani; Francesco Lauria; Damiano Rondelli; D Benfenati; Donatella Raspadori; Monica Bocchia; Maurizio Bendandi; Alessandro Gozzetti; Francesco Zaja; Renato Fanin
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(7):575-8.
1993: Sante Tura; M Fiacchini; Pier Luigi Zinzani; E Brusamolino; P G Gobbi
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):925-30.
1993: Pier Luigi Zinzani; Maurizio Martelli; Sante Tura; Franco Mandelli
Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma.
Haematologica 1993;78(1):40-3.
1992: Patrizio Mazza; Monica Bocchia; Pier Luigi Zinzani; M Fiacchini; Filippo Gherlinzoni; Giuseppe Bandini; Maurizio Bendandi; Giovanni P Frezza; Stefano Neri; Enza Barbieri
Hodgkin's disease: summary of twenty years' experience.
Haematologica 1992;77(6):487-93.
1992: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; Monica Bocchia; M Fiacchini; Maurizio Bendandi; Enza Barbieri; Giovanni P Frezza; Stefano Neri; E Aitini
Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment.
Leukemia & lymphoma 1992;8(1-2):81-5.
1992: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; Monica Bocchia; Maurizio Bendandi; M Fiacchini; Sante Tura
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon.
Haematologica 1992;77(5):435-7.
1992: Pier Luigi Zinzani; Francesco Lauria; Donatella Raspadori; Damiano Rondelli; D Benfenati; S Pileri; Elena Sabattini; Sante Tura
Results in hairy-cell leukemia patients treated with alpha-interferon: predictive prognostic factors.
European journal of haematology 1992;49(3):133-7.
1992: Francesco Lauria; Damiano Rondelli; Donatella Raspadori; Pier Luigi Zinzani; D Benfenati; S Pileri; Elena Sabattini; Sante Tura
Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.
Leukemia & lymphoma 1992;7(1-2):103-7.
1991: Pier Luigi Zinzani; M Fiacchini; Patrizio Mazza; Filippo Gherlinzoni; Monica Bocchia; Sante Tura
Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Haematologica 1991;76(4):305-10.
1991: Sante Tura; George P Canellos; A Goldstone; Dan Longo; A McMillan; W Urba; Pier Luigi Zinzani
Hodgkin's disease: controversies and challenges for the future.
Haematologica 1991;76(4):263-79.
1991: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; R Zanchini; Monica Bocchia; Sante Tura
Mycosis fungoides: a therapeutical review.
Haematologica 1991;76(2):150-61.
1991: Filippo Gherlinzoni; Patrizio Mazza; Monica Bocchia; Pier Luigi Zinzani; M Fiacchini; R Zanchini; S Pileri; Sante Tura
Stage I high-grade non-Hodgkin's lymphomas: a retrospective analysis.
Haematologica 1991;76(1):38-42.
1991: Pier Luigi Zinzani; Francesco Lauria; Donatella Raspadori; M Buzzi; D Benfenati; Monica Bocchia; Damiano Rondelli; Sante Tura
Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment.
Acta haematologica 1991;85(1):16-9.
1991: Sante Tura; Franco Mandelli; Patrizio Mazza; S Pileri; Filippo Gherlinzoni; Monica Bocchia; Pier Luigi Zinzani; M Fiacchini; Maurizio Martelli; G Papa
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Leukemia 1991;5 Suppl 1():74-8.
1991: Patrizio Mazza; Monica Bocchia; R Zanchini; Filippo Gherlinzoni; Pier Luigi Zinzani; S Pileri; Sante Tura
MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?
Haematologica 1991;76(1):47-52.
1990: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; R Zanchini; Monica Bocchia; E Aitini; Giovanna Cavazzini; B Amurri; marco gobbi; Sante Tura
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Tumori 1990;76(6):533-6.
1990: Patrizio Mazza; Monica Bocchia; Pier Luigi Zinzani; Filippo Gherlinzoni; P L Ghetti
[Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)].
Haematologica 1990;75 Suppl 4():78-81.
1990: Francesco Lauria; Donatella Raspadori; R Foa; Pier Luigi Zinzani; M Buzzi; Luigi Gugliotta; S Macchi; Sante Tura
Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype.
Cancer 1990;65(10):2233-6.
1990: Filippo Gherlinzoni; Patrizio Mazza; Pier Luigi Zinzani; Sante Tura; F Lanza; G Castoldi; Giampiero Bellesi; Pierluigi Rossi Ferrini; L Mangoni; V Rizzoli
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.
Blut 1990;60(3):172-6.
1990: Pier Luigi Zinzani; Francesco Lauria; M Buzzi; Donatella Raspadori; Luigi Gugliotta; Monica Bocchia; S Macchi; R Algeri; Sante Tura
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases.
Haematologica 1990;75(1):54-7.
1990: Francesco Lauria; Pier Luigi Zinzani; Donatella Raspadori; R Foà; M Buzzi; Luigi Gugliotta; Monica Bocchia; D Benfenati; Sante Tura
Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.
European journal of haematology. Supplementum 1990;52():3-6.
1990: P Mazza; Sante Tura; Monica Bocchia; Pier Luigi Zinzani; F Gherlinzoni; F Mandelli; M P Anselmo; G Papa; M Antimi; P G Gobbi
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective.
European journal of haematology. Supplementum 1990;52():22-4.
1989: Sante Tura; Patrizio Mazza; Filippo Gherlinzoni; Pier Luigi Zinzani; G Poletti; Giuseppe Visani; Roberto M Lemoli; Michele Cavo; Piero Galieni; Cristina Tassi
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
Cancer chemotherapy and pharmacology 1989;23(2):123-5.
1989: Francesco Lauria; R Foà; Donatella Raspadori; S Pileri; A Tassinari; M Buzzi; Alfonso Zaccaria; Pier Luigi Zinzani; Sante Tura
Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.
Bone marrow transplantation 1989;4 Suppl 1():176-8.
1988: Sante Tura; Patrizio Mazza; Filippo Gherlinzoni; Pier Luigi Zinzani; G Poletti; Giuseppe Visani; Roberto M Lemoli; G Bandini; Michele Cavo; Piero Galieni
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
Haematologica 1988;73(6):503-8.
1988: Patrizio Mazza; G Poletti; Pier Luigi Zinzani; Filippo Gherlinzoni; G Miniaci; E Tonielli; R Sciascia; Sante Tura
Critical value of laparotomy with splenectomy in stage III Hodgkin's disease as restaging procedure after chemotherapy.
European journal of haematology 1988;41(1):6-11.
1988: Francesco Lauria; Gian Paolo Bagnara; Anna Guarini; Lucia Catani; L Gaggioli; Luigi Gugliotta; Donatella Raspadori; S Macchi; giorgio zauli; Pier Luigi Zinzani
Reduced bone marrow colony growth in hairy-cell leukemia before and after interferon-alpha treatment. Possible inhibitory role of a serological factor.
Haematologica 1988;73(3):191-4.
1988: Francesco Lauria; R Foà; Donatella Raspadori; Pier Luigi Zinzani; M Buzzi; Maria Teresa Fierro; M Bonferroni; Renato Fanin; C Gallizia; Mariagrazia Michieli
Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
European journal of cancer & clinical oncology 1988;24(2):195-200.
1987: Patrizio Mazza; Filippo Gherlinzoni; G Kemna; G Poletti; Pier Luigi Zinzani; F Verlicchi; F Lauria; M Fiacchini; S Pileri; M T Rivano
Clinicopathological study on non-Hodgkin's lymphomas.
Haematologica 1987;72(4):351-7.
1987: Filippo Gherlinzoni; Pier Luigi Zinzani; F Lauria; Patrizio Mazza; Enza Barbieri; E Emiliani; M Fiacchini; Stefano Neri; G Poletti; S Tura
Re-evaluation of prognosis in stages I and II Hodgkin's disease with bulky mediastinal involvement.
Haematologica 1987;72(3):237-9.
1987: Pier Luigi Zinzani; Filippo Gherlinzoni; F Lauria; Patrizio Mazza; Enza Barbieri; E Emiliani; M Tabanelli; S Tura
Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas.
Tumori 1987;73(2):121-6.
1987: Robin Foa; Maria Teresa Fierro; P Lusso; M Bonferroni; Donatella Raspadori; M Buzzi; Pier Luigi Zinzani; Luigi Resegotti; Francesco Lauria
Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
Leukemia 1987;1(4):377-9.
1986: Sante Tura; Patrizio Mazza; Pier Luigi Zinzani; F Verlicchi; Michele Baccarani; F Lauria; M Fiacchini; marco gobbi; Giuseppe Bandini; E Emiliani
Hodgkin's disease (HD): a historical perspective.
European journal of cancer & clinical oncology 1986;22(11):1315-23.